HR Execs on the Move

Athletico Physical Therapy

www.athletico.com

 
For more than 25 years we`ve been helping remove pain and discomfort from people`s lives. Our patients trust in our expertise` which is why 98 percent would recommend us to a friend – because we were able to help make their lives better. – Athletico Physical Therapy` Better for Every Body. Athletico Physical Therapy provides the highest quality orthopedic rehabilitation services to communities` employers and athletes` with over 450 locations throughout twelve states. To demonstrate our commitment to both our patients and referring physicians` we measure functional patient outcomes and patient satisfaction with national data comparison using a third-party outcomes system. ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
David Tipton
 Chief HR Officer Profile
David T
 Chief Human Resources Officer Profile
Taylor Williams
 Vice President of Revenue Cycle Profile
Khymberly Booth
 Chief Human Resource Officer Profile

Similar Companies

AKH

AKH is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jackson Park Christian Home

Jackson Park Christian Home is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Neurostream Technologies

Neurostream Technologies is a Saint-Augustin-De-Desmaures, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Kemberton

Kemberton is a leading provider of technology-enabled revenue cycle management services to hospitals for complex claims. We specialize in the management and collection of workers compensation, motor vehicle accident claims, veteran administration and the resolution of insurance denials for hospitals and physician practice groups. Kemberton helps accelerate collection times and maximize reimbursements for over 300 hospital clients across 35 states, resulting in over $1.5 billion dollars of incremental cash payments for our clients.